0000950170-23-046396.txt : 20230905 0000950170-23-046396.hdr.sgml : 20230905 20230905161557 ACCESSION NUMBER: 0000950170-23-046396 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230905 DATE AS OF CHANGE: 20230905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King-Jones Heidy CENTRAL INDEX KEY: 0001794898 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 231235950 MAIL ADDRESS: STREET 1: C/O AXCELLA HEALTH INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 17, SUITE 102B CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 17, SUITE 102B CITY: WALTHAM STATE: MA ZIP: 02453 4 1 ownership.xml 4 X0508 4 2023-09-01 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001794898 King-Jones Heidy 221 CRESCENT STREET, BUILDING 23, SUITE 105 WALTHAM MA 02453 false true false false See Remarks false Stock Option (Right to Buy) 0.58 2023-09-01 4 A false 13495255 0.00 A 2033-09-01 Common Stock 13495255 13495255 D This option represents the right to purchase 13,495,255 shares of the Issuer's common stock, one quarter of which will vest and become exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer. Chief Legal Officer and Corporate Secretary /s/ Scott Burrows, by power of attorney 2023-09-05